1. Home
  2. VTAK vs BJDX Comparison

VTAK vs BJDX Comparison

Compare VTAK & BJDX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • VTAK
  • BJDX
  • Stock Information
  • Founded
  • VTAK 2002
  • BJDX 2015
  • Country
  • VTAK United States
  • BJDX United States
  • Employees
  • VTAK N/A
  • BJDX N/A
  • Industry
  • VTAK Medical/Dental Instruments
  • BJDX Medical Specialities
  • Sector
  • VTAK Health Care
  • BJDX Health Care
  • Exchange
  • VTAK Nasdaq
  • BJDX Nasdaq
  • Market Cap
  • VTAK 3.1M
  • BJDX 2.9M
  • IPO Year
  • VTAK 2018
  • BJDX 2021
  • Fundamental
  • Price
  • VTAK $0.17
  • BJDX $1.49
  • Analyst Decision
  • VTAK
  • BJDX
  • Analyst Count
  • VTAK 0
  • BJDX 0
  • Target Price
  • VTAK N/A
  • BJDX N/A
  • AVG Volume (30 Days)
  • VTAK 1.9M
  • BJDX 32.4K
  • Earning Date
  • VTAK 08-13-2025
  • BJDX 08-13-2025
  • Dividend Yield
  • VTAK N/A
  • BJDX N/A
  • EPS Growth
  • VTAK N/A
  • BJDX N/A
  • EPS
  • VTAK N/A
  • BJDX N/A
  • Revenue
  • VTAK $481,000.00
  • BJDX N/A
  • Revenue This Year
  • VTAK $822.86
  • BJDX N/A
  • Revenue Next Year
  • VTAK $168.42
  • BJDX $55.56
  • P/E Ratio
  • VTAK N/A
  • BJDX N/A
  • Revenue Growth
  • VTAK 9.57
  • BJDX N/A
  • 52 Week Low
  • VTAK $0.15
  • BJDX $1.46
  • 52 Week High
  • VTAK $2.49
  • BJDX $37.50
  • Technical
  • Relative Strength Index (RSI)
  • VTAK 31.31
  • BJDX 39.72
  • Support Level
  • VTAK $0.20
  • BJDX $1.52
  • Resistance Level
  • VTAK $0.24
  • BJDX $1.63
  • Average True Range (ATR)
  • VTAK 0.02
  • BJDX 0.07
  • MACD
  • VTAK -0.01
  • BJDX -0.00
  • Stochastic Oscillator
  • VTAK 4.13
  • BJDX 11.54

About VTAK Catheter Precision Inc.

Catheter Precision Inc is engaged in design, manufacture and sale of new and innovative medical technologies primarily focused in the field of cardiac electrophysiology, or EP. The Company's primary product is the View into Ventricular Onset System (VIVO or VIVO System), which is a non-invasive imaging system that offers 3D cardiac mapping to help with localizing the sites of origin of idiopathic ventricular arrhythmias in patients with structurally normal hearts prior to EP procedures. The VIVO system has achieved a CE Mark allowing it to be commercialized in the European Union and has been placed at several hospitals in Europe. Its newest product, the Surgical Vessel Closing Pressure Device (LockeT), is a suture retention device indicated for wound healing by distributing suture tension.

About BJDX Bluejay Diagnostics Inc.

Bluejay Diagnostics Inc is a medical diagnostics company. It is developing rapid tests using whole blood using its Symphony technology platform to improve patient outcomes in critical care settings. The company's first product, the Symphony IL-6 test, is for the monitoring of disease progression in critical care settings and is a clinically established inflammatory biomarker for the assessment of the severity of infection and inflammation across many disease indications, including sepsis.

Share on Social Networks: